Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
This study is currently recruiting participants.
Verified December 2012 by Vanderbilt University
Sponsor:
Vanderbilt University
Collaborator:
Information provided by (Responsible Party):
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00898638
First received: May 9, 2009
Last updated: March 28, 2013
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Collecting and storing samples of tissue, saliva, and blood from patients with cancer and from healthy participants to study in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing tissue samples from patients with head and neck cancer and from healthy participants.
| Condition | Intervention |
|---|---|
|
Head and Neck Cancer |
Other: biologic sample preservation procedure Other: medical chart review |
| Study Type: | Observational |
| Official Title: | Head and Neck Tumor Tissue Repository and Clinical Database |
Resource links provided by NLM:
Further study details as provided by Vanderbilt University:
Primary Outcome Measures:
- Maintenance of a clinical database pertaining to diagnosis and treatment outcome of patients with head and neck cancer [ Designated as safety issue: No ]
- Development of a repository of biospecimens [ Designated as safety issue: No ]
| Study Start Date: | February 2003 |
OBJECTIVES:
- Maintain and update a clinical database pertaining to diagnosis and treatment outcome of patients with head and neck cancer.
- Develop a repository of biospecimens from these patients.
OUTLINE: Tumor tissue samples and/or bronchial washings are collected from patients undergoing planned surgery and/or bronchoscopy, respectively. Buccal swabs and/or mouthwash samples and saliva samples are collected. Patients also undergo blood sample collection at baseline and then every 2-6 months thereafter.
Healthy participants contribute blood samples, buccal swabs, and mouthwash samples at baseline only.
Information about medical and family history and cancer risk factors is also collected.
PROJECTED ACCRUAL: No limit.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
DISEASE CHARACTERISTICS:
Meets 1 of the following criteria:
Diagnosis of head and neck cancer
- Being treated at Vanderbilt University Medical Center for the cancer
- Healthy participant
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00898638
Locations
| United States, Tennessee | |
| Vanderbilt-Ingram Cancer Center - Cool Springs | Recruiting |
| Nashville, Tennessee, United States, 37064 | |
| Contact: Wendell G Yarbrough 615-343-8840 | |
| Vanderbilt-Ingram Cancer Center at Franklin | Recruiting |
| Nashville, Tennessee, United States, 37064 | |
| Contact: Wendell G Yarbrough 615-343-8840 | |
| Vanderbilt-Ingram Cancer Center | Recruiting |
| Nashville, Tennessee, United States, 37232-6838 | |
| Contact: Clinical Trials Office - Vanderbilt-Ingram Cancer Center 800-811-8480 | |
| Veterans Affairs Medical Center - Nashville | Recruiting |
| Nashville, Tennessee, United States, 37212 | |
| Contact: Clinical Trials Office - Veterans Affairs Medical Center - Nas 615-327-4751 | |
Sponsors and Collaborators
Vanderbilt University
Investigators
| Study Chair: | Wendell G. Yarbrough, MD, FACS | Vanderbilt-Ingram Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | Vanderbilt University |
| ClinicalTrials.gov Identifier: | NCT00898638 History of Changes |
| Other Study ID Numbers: | CDR0000546682, P30CA068485, VU-VICC-HN-0356, VU-VICC-IRB-030062 |
| Study First Received: | May 9, 2009 |
| Last Updated: | March 28, 2013 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government |
Keywords provided by Vanderbilt University:
|
stage I squamous cell carcinoma of the hypopharynx stage II squamous cell carcinoma of the hypopharynx stage III squamous cell carcinoma of the hypopharynx stage IV squamous cell carcinoma of the hypopharynx recurrent squamous cell carcinoma of the hypopharynx stage I squamous cell carcinoma of the larynx stage I verrucous carcinoma of the larynx stage II squamous cell carcinoma of the larynx stage II verrucous carcinoma of the larynx stage III squamous cell carcinoma of the larynx stage III verrucous carcinoma of the larynx stage IV squamous cell carcinoma of the larynx stage IV verrucous carcinoma of the larynx recurrent squamous cell carcinoma of the larynx recurrent verrucous carcinoma of the larynx |
stage I adenoid cystic carcinoma of the oral cavity stage I basal cell carcinoma of the lip stage I mucoepidermoid carcinoma of the oral cavity stage I squamous cell carcinoma of the lip and oral cavity stage I verrucous carcinoma of the oral cavity stage II adenoid cystic carcinoma of the oral cavity stage II basal cell carcinoma of the lip stage II mucoepidermoid carcinoma of the oral cavity stage II squamous cell carcinoma of the lip and oral cavity stage II verrucous carcinoma of the oral cavity stage III adenoid cystic carcinoma of the oral cavity stage III basal cell carcinoma of the lip stage III mucoepidermoid carcinoma of the oral cavity stage III squamous cell carcinoma of the lip and oral cavity stage III verrucous carcinoma of the oral cavity |
Additional relevant MeSH terms:
|
Head and Neck Neoplasms Neoplasms by Site Neoplasms |
ClinicalTrials.gov processed this record on May 16, 2013